Ovation Science

Ovation Science Liabilities

The The Liabilities of Ovation Science (OVAT.CN) as of Nov 10, 2026 is 1.54 M CAD. In the previous year, The Liabilities was 1.15 M CAD — a change of 33.57% (higher).

Liabilities

1.54 MCAD

YoY

33.57%

Last updated:

In 2025, Ovation Science's total liabilities amounted to 1.54 M CAD, a 33.57% difference from the 1.15 M CAD total liabilities in the previous year.

The Ovation Science Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
535,841.00 CAD
Jan 1, 2019
362,236.00 CAD
Jan 1, 2020
143,383.00 CAD
Jan 1, 2021
63,741.00 CAD
Jan 1, 2022
187,838.00 CAD
Jan 1, 2023
728,992.00 CAD
Jan 1, 2024
1.15 M CAD
Jan 1, 2025
1.54 M CAD
The Ovation Science Liabilities history
YEARLiabilitiesYoY
1.54 MCAD+33.57%
1.15 MCAD+58.34%
728,992.00CAD+288.10%
187,838.00CAD+194.69%
63,741.00CAD-55.54%
143,383.00CAD-60.42%
362,236.00CAD-32.40%
535,841.00CAD+60.48%
333,906.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ovation Science Stock analysis

What does Ovation Science do? Ovation Science, Inc. generates revenue through the development and sale of topical and transdermal skin products utilizing its patented Invisicare delivery technology. The company offers products under the Ovation brand, ARLO CBD Beauty, and InVibe MD, featuring formulations with hemp seed oil, CBD, THC, and cannabinoid derivatives. These products are distributed through direct sales and licensing agreements, targeting consumers seeking science-based skincare and wellness solutions. The firm leverages its Invisicare technology to create creams and lotions that deliver cannabinoids and hemp seed oil effectively for topical and transdermal use. The company's product portfolio includes ARLO CBD Beauty for skincare and InVibe MD for wellness, both powered by the Invisicare delivery system. Ovation Science licenses its technology and products to third parties while also selling directly under its own brands. The primary market segments are consumers interested in cannabinoid-based skincare and wellness products, with a focus on the efficacy and science-backed nature of their formulations. All products are manufactured and distributed under the company's brand labels, emphasizing the patented delivery system as a key differentiator. Ovation Science, Inc. monetizes its patented Invisicare technology by developing and distributing products containing cannabinoids, hemp seed oil, and synthetic cannabis derivatives. The company's revenue streams come from both direct sales of Ovation-branded products and licensing agreements for its technology and formulations. The firm's focus on topical and transdermal delivery ensures that its products are positioned within the growing market for cannabinoid-infused skincare and wellness solutions, targeting customers who prioritize the science and technology behind their skincare products. Ovation Science is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Ovation Science's Liabilities

Ovation Science's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ovation Science's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ovation Science's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ovation Science's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ovation Science’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ovation Science stock

The Liabilities of Ovation Science is 1.54 M CAD in 2025.

The Liabilities of Ovation Science changed from 1.15 M CAD to 1.54 M CAD, representing a 33.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Ovation Science since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Ovation Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Ovation Science

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Ovation Science